Hypothesis

Transient senescent fibroblasts secrete a heparan sulfate (HS)-bound isoform of PDGF-AA that creates a stable, gradient‑rich microenvironment essential for recruiting myeloid progenitors and organizing extracellular matrix ( ECM ) remodeling during acute wound healing. Chronic senescent fibroblasts lose HS chain polymerization due to upregulation of heparanase and downregulation of the HS biosynthetic enzyme Ext1, shifting PDGF-AA secretion to a free, diffusible form that fails to establish spatial cues, thereby driving disordered inflammation and fibrosis. Selective inhibition of heparanase or restoration of Ext1 activity in chronically senescent cells should preserve the beneficial HS‑PDGF‑AA gradient while attenuating the pathological SASP, allowing discrimination between chaperone and witness populations.

Mechanistic Rationale

1. HS‑PDGF‑AA as a spatial organizer – HS proteoglycans sequester specific growth factor isoforms, converting soluble signals into immobilized gradients that guide cell migration and polarization. Transient senescent fibroblasts, enriched for developmental programs [2], likely upregulate Ext2/Ext1 to produce long HS chains that bind PDGF‑AA with high affinity, presenting it to CXCR4^+ myeloid progenitors and facilitating precise angiogenic sprouting. This matches observations that exogenous PDGF‑AA rescues senescence‑free wounds only when delivered in a matrix‑bound format [3].

2. Loss of HS remodeling in chronic senescence – Persistent senescent cells exhibit a pro‑inflammatory SASP rich in heparanase (HPSE) and matrix metalloproteinases that cleave HS chains [4,5]. HS truncation reduces PDGF‑AA binding affinity, releasing the cytokine into the soluble phase. Soluble PDGF‑AA then activates PDGFRβ on resident fibroblasts in a non‑gradient manner, promoting myofibroblast differentiation and perivascular fibrosis, as seen when liver sinusoidal endothelial senescent cells are continuously cleared [5].

3. Functional consequence – The HS‑bound PDGF‑AA gradient sustains a transient, self‑limiting recruitment of immune cells that clear debris and then depart, whereas the soluble form creates a chronic, autocrine loop that maintains fibroblast activation and sustains NF‑κB‑driven SASP, converting the senescent cell from a chaperone into a witness.

Testable Predictions

• Prediction 1: In murine excisional wounds collected at 4‑7 days post‑injury (transient senescence peak), PDGF‑AA will co‑immunoprecipitate with HS chains of >50 kDa, whereas at >14 days (chronic senescence) PDGF‑AA will be predominantly free in wound fluid. This can be measured by HS‑affinity pull‑down followed by ELISA for PDGF‑AA [1,3].
• Prediction 2: Genetic deletion of Ext1 specifically in fibroblasts (using Fsp1‑Cre) will phenocopy chronic senescence: wounds will show delayed closure, increased soluble PDGF‑AA, and elevated collagen deposition despite normal p16^INK4a^+ cell numbers.
• Prediction 3: Pharmacological inhibition of heparanase (e.g., with PI‑88) administered after day 7 will restore HS‑PDGF‑AA complexes, reduce soluble PDGF‑AA, improve re‑epithelialization, and limit fibrosis without reducing total senescent cell burden.
• Prediction 4: Single‑cell RNA‑seq coupled with spatial transcriptomics of wound edges will reveal a transient senescent fibroblast cluster expressing high Ext1, Hspg2, and Pdgfa, whereas a chronic cluster will show high Hpse, Mmp9, and low Hspg2.

Falsifiability

If HS‑PDGF‑AA gradient formation is not differentially regulated between transient and chronic senescent fibroblasts—for example, if HS chain length and PDGF‑AA binding remain unchanged across time points, or if Ext1/heparanase manipulation fails to shift the balance between soluble and bound PDGF‑AA without affecting senescence markers—the hypothesis would be falsified. Similarly, if heparanase inhibition does not ameliorate fibrosis or restore wound healing despite normalizing HS‑PDGF‑AA levels, the proposed mechanistic link would be refuted.

Implications

This framework refines the senolytic paradigm: instead of indiscriminate p16^INK4a^+ clearance, targeting the HS‑PDGF‑AA axis could selectively silence the pathological SASP of chronic senescent witnesses while preserving the regenerative chaperone function of transient senescent cells, thereby avoiding collateral damage to tissue repair.